Intercept Pharmaceuticals ICPT is an emerging biotechnology company with one of the most advanced pipeline candidates for nonalcoholic steatohepatitis, or NASH, a massive market with high unmet need.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback